Citigroup
NUVB icon

Citigroup’s Nuvation Bio NUVB Stock Holding History

Citigroup’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.35M Buy
315,776
+252,694
+401% +$1.41M ﹤0.01% 2916
2025
Q4 		$565K Sell
63,082
-859,815
-93% -$5.33M ﹤0.01% 3512
2025
Q3 		$3.41M Sell
922,897
-399,962
-30% -$1.09M ﹤0.01% 2260
2025
Q2 		$2.58M Buy
1,322,859
+576,765
+77% +$1.2M ﹤0.01% 2423
2025
Q1 		$1.31M Sell
746,094
-106,661
-13% -$243K ﹤0.01% 3051
2024
Q4 		$2.27M Buy
852,755
+21,211
+3% +$54.6K ﹤0.01% 2715
2024
Q3 		$1.9M Buy
831,544
+103,816
+14% +$317K ﹤0.01% 2706
2024
Q2 		$2.12M Buy
727,728
+22,323
+3% +$68.1K ﹤0.01% 2302
2024
Q1 		$2.57M Sell
705,405
-350,654
-33% -$673K ﹤0.01% 2239
2023
Q4 		$1.59M Buy
1,056,059
+1,054,766
+81,575% +$1.36M ﹤0.01% 2434
2023
Q3 		$1.73K Sell
1,293
-69,107
-98% -$115K ﹤0.01% 5001
2023
Q2 		$127K Buy
70,400
+32,926
+88% +$56K ﹤0.01% 4123
2023
Q1 		$62.2K Buy
37,474
+20,720
+124% +$42K ﹤0.01% 4202
2022
Q4 		$32.2K Sell
16,754
-6,493
-28% -$13.1K ﹤0.01% 4419
2022
Q3 		$52K Sell
23,247
-6,049
-21% -$17.3K ﹤0.01% 4364
2022
Q2 		$95K Sell
29,296
-8,740
-23% -$38.1K ﹤0.01% 4246
2022
Q1 		$200K Sell
38,036
-5,866
-13% -$33K ﹤0.01% 4077
2021
Q4 		$373K Buy
43,902
+14,380
+49% +$132K ﹤0.01% 3983
2021
Q3 		$293K Buy
29,522
+15,072
+104% +$137K ﹤0.01% 3926
2021
Q2 		$135K Buy
+14,450
New +$165K ﹤0.01% 4407

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup's NUVB Position: Q1 2026 in Review

Citigroup increased its Nuvation Bio (NUVB) stake by 401% in Q1 2026, buying an estimated $1.41M and bringing the position to 315,776 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #2916.

Citigroup first reported a position in NUVB in Q2 2021 and has held it in 20 quarters since. The position peaked at $3.41M in Q3 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Citigroup held 315,776 shares of Nuvation Bio worth $1.35M as of Q1 2026.
  • Citigroup bought 252,694 Nuvation Bio shares in Q1 2026, an estimated $1.41M.
  • Nuvation Bio made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #2916 holding.
  • Citigroup first reported a position in Nuvation Bio in Q2 2021 and has held it in 20 quarters since.
  • Citigroup's Nuvation Bio position peaked at $3.41M in Q3 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.